금연 치료제 시장 보고서(2026년)

Quit-smoking medications are specific treatments that help individuals stop smoking by reducing cravings and alleviating other nicotine withdrawal symptoms. These drugs deliver nicotine in a different form, such as through chewing gum or patches, for a limited time, helping to ease withdrawal symptoms and the desire to smoke.

The primary products in the quit-smoking medication category include drug therapies, electronic cigarettes, nicotine inhalers, nicotine replacement therapies, and nicotine sublingual tablets. Drug therapy involves the use of medications to treat or prevent diseases. Medications like Varenicline (Chantix), Bupropion (Zyban), and others can be found at drug stores, online pharmacies, and retail pharmacies.

Tariffs on imported pharmaceutical ingredients and electronic components have posed challenges for the quit smoking drugs market by increasing production costs and delaying supply chain timelines. Segments such as e-cigarettes and nicotine inhalers are particularly affected, especially in regions like North America and Europe that rely on imported components. However, tariffs have also encouraged local manufacturing investments and innovation in cost-effective nicotine delivery solutions, potentially strengthening regional production capabilities and resilience against global supply disruption

The quit smoking drugs market research report is one of a series of new reports from The Business Research Company that provides quit smoking drugs market statistics, including quit smoking drugs industry global market size, regional shares, competitors with a quit smoking drugs market share, detailed quit smoking drugs market segments, market trends and opportunities, and any further data you may need to thrive in the quit smoking drugs industry. This quit smoking drugs market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenario of the industry.

The quit smoking drugs market size has grown rapidly in recent years. It will grow from $44.23 billion in 2025 to $50.94 billion in 2026 at a compound annual growth rate (CAGR) of 15.2%. The growth in the historic period can be attributed to increasing awareness of smoking hazards, rising prevalence of smoking-related diseases, availability of nicotine replacement therapies, government anti-smoking campaigns, growth of pharmaceutical manufacturing in emerging markets.

The quit smoking drugs market size is expected to see rapid growth in the next few years. It will grow to $90.73 billion in 2030 at a compound annual growth rate (CAGR) of 15.5%. The growth in the forecast period can be attributed to advancement in digital health solutions, rising adoption of personalized medicine, integration of ai in treatment monitoring, expansion of telemedicine services, growth of wearable health monitoring devices. Major trends in the forecast period include personalized nicotine replacement therapies, mobile health (mhealth) & smoking cessation apps, telemedicine-driven prescription support, behavioral therapy integration with drug therapy, wearable devices for monitoring cravings.

The increasing prevalence of smoking addiction is anticipated to drive the growth of the quit-smoking drug market in the future. Smoking involves inhaling and exhaling the vapors of burning plant materials such as tobacco, marijuana, hashish, and others. Quit-smoking drugs are used to reduce the desire to smoke by suppressing the craving for tobacco, and they are prescribed to manage nicotine withdrawal symptoms to aid in quitting smoking effectively. For example, in November 2025, the OECD (Organisation for Economic Co-operation and Development), a France-based international organization, reported that 14.8% of people aged 15 and older smoked daily in 2023. The highest rates of daily smoking were observed in Turkiye, Hungary, Greece, as well as in Indonesia, Bulgaria, and China, where at least one in four people smoked daily. On average, 18.5% of men smoked daily in 2023, compared to 11.4% of women. Therefore, the growing prevalence of smoking addiction is contributing to the expansion of the quit-smoking drug market.

Key companies in the quit-smoking drug market are focusing on developing new formulations and delivery methods, such as generic tablets, to strengthen their market position across regions and gain a competitive advantage. Generic varenicline tablets are non-branded versions containing varenicline tartrate, which are bioequivalent to the original branded product and used for smoking cessation therapy. For example, in January 2024, Lupin Limited, an India-based pharmaceutical company, launched new Varenicline tablets in the United States, available in 0.5 mg and 1 mg strengths. These tablets are generic versions of Chantix tablets (0.5 mg and 1 mg) from PF Prism C.V. and are used to support smoking cessation treatment. Varenicline, a partial agonist of the nicotinic acetylcholine receptor, works by stimulating the release of dopamine, which helps reduce withdrawal symptoms and cravings associated with nicotine addiction. This dual mechanism allows it to lessen the pleasurable effects of smoking while providing some stimulation to minimize withdrawal effects.

In September 2024, Dr. Reddy's Laboratories, an India-based pharmaceutical company, acquired the nicotine replacement therapy business from Haleon plc for $680 million (£500 million). The acquisition aims to strengthen Dr. Reddy's position in the global consumer healthcare market, especially by enhancing its over-the-counter (OTC) offerings and expanding its presence in key international markets outside the United States. Haleon plc is a UK-based consumer health company specializing in nicotine addiction treatments.

Major companies operating in the quit smoking drugs market are 22nd Century Group, Cipla Limited, Dr. Reddy's Laboratories, GSK Plc., Johnson & Johnson, NJOY LLC, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, BioCorRx Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Hikma Pharmaceuticals PLC, IntelGenx Technologies Corp., Innovus Pharmaceuticals Inc., Gilla Inc., Rusan Pharma Ltd., Novartis AG

North America was the largest region in the quit smoking drugs market in 2025. The regions covered in the quit smoking drugs market report are Asia-Pacific, South East Asia, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

The countries covered in the quit smoking drugs market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Taiwan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The quit-smoking drugs market consists of sales of AXS-05, cytisincline, nadolol, and liraglutide. Values in this market are 'factory gate' values, that is the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Quit Smoking Drugs Market Global Report 2026 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses quit smoking drugs market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

• Gain a truly global perspective with the most comprehensive report available on this market covering 16 geographies.
• Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, inflation and interest rate fluctuations, and evolving regulatory landscapes.
• Create regional and country strategies on the basis of local data and analysis.
• Identify growth segments for investment.
• Outperform competitors using forecast data and the drivers and trends shaping the market.
• Understand customers based on end user analysis.
• Benchmark performance against key competitors based on market share, innovation, and brand strength.
• Evaluate the total addressable market (TAM) and market attractiveness scoring to measure market potential.
• Suitable for supporting your internal and external presentations with reliable high-quality data and analysis
• Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
• All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for quit smoking drugs ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The quit smoking drugs market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, total addressable market (TAM), market attractiveness score (MAS), competitive landscape, market shares, company scoring matrix, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

• The market characteristics section of the report defines and explains the market. This section also examines key products and services offered in the market, evaluates brand-level differentiation, compares product features, and highlights major innovation and product development trends.
• The supply chain analysis section provides an overview of the entire value chain, including key raw materials, resources, and supplier analysis. It also provides a list competitor at each level of the supply chain.
• The updated trends and strategies section analyses the shape of the market as it evolves and highlights emerging technology trends such as digital transformation, automation, sustainability initiatives, and AI-driven innovation. It suggests how companies can leverage these advancements to strengthen their market position and achieve competitive differentiation.
• The regulatory and investment landscape section provides an overview of the key regulatory frameworks, regularity bodies, associations, and government policies influencing the market. It also examines major investment flows, incentives, and funding trends shaping industry growth and innovation.
• The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
• The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.
• The total addressable market (TAM) analysis section defines and estimates the market potential compares it with the current market size, and provides strategic insights and growth opportunities based on this evaluation.
• The market attractiveness scoring section evaluates the market based on a quantitative scoring framework that considers growth potential, competitive dynamics, strategic fit, and risk profile. It also provides interpretive insights and strategic implications for decision-makers.
• Market segmentations break down the market into sub markets.
• The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
• Expanded geographical coverage includes Taiwan and Southeast Asia, reflecting recent supply chain realignments and manufacturing shifts in the region. This section analyzes how these markets are becoming increasingly important hubs in the global value chain.
• The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
• The company scoring matrix section evaluates and ranks leading companies based on a multi-parameter framework that includes market share or revenues, product innovation, and brand recognition.

Scope

• Markets Covered:1) By Product: Drug Therapy; E-Cigarettes; Nicotine Inhalers; Nicotine Replacement Therapies; Nicotine Sublingual Tablets
• 2) By Drug: Varenicline (Chantix); Bupropion (Zyban); Other Drugs
• 3) By Distribution: Drug Store; Online Pharmacies; Retail Pharmacies
• Subsegments:
• 1) By Drug Therapy: Bupropion (Zyban); Varenicline (Chantix)
• 2) By E-Cigarettes: Disposable E-Cigarettes; Rechargeable E-Cigarettes; Pod Systems
• 3) By Nicotine Inhalers: Prescription Inhalers; Over-The-Counter Inhalers
• 4) By Nicotine Replacement Therapies (NRT): Nicotine Patches; Nicotine Gum; Nicotine Lozenges
• 5) By Nicotine Sublingual Tablets: Fast-Acting Sublingual Tablets; Extended-Release Sublingual Tablets
• Companies Mentioned: 22nd Century Group; Cipla Limited; Dr. Reddy's Laboratories; GSK Plc.; Johnson & Johnson; NJOY LLC; Perrigo Company Plc; Pfizer Inc.; Philip Morris International; Glenmark Pharmaceuticals Limited; Zydus Cadila Healthcare Limited; BioCorRx Inc.; Ennaid Therapeutics LLC; Fertin Pharma A/S; Hikma Pharmaceuticals PLC; IntelGenx Technologies Corp.; Innovus Pharmaceuticals Inc.; Gilla Inc.; Rusan Pharma Ltd.; Novartis AG
• Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Taiwan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
• Regions: Asia-Pacific; South East Asia; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
• Time Series: Five years historic and ten years forecast.
• Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
• Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
• Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
• Delivery Format: Word, PDF or Interactive Report
• + Excel Dashboard
• Added Benefits
• Bi-Annual Data Update
• Customisation
• Expert Consultant Support

Added Benefits available all on all list-price licence purchases, to be claimed at time of purchase. Customisations within report scope and limited to 20% of content and consultant support time limited to 8 hours.

Table of Contents

1. Executive Summary

• 1.1. Key Market Insights (2020-2035)
• 1.2. Visual Dashboard: Market Size, Growth Rate, Hotspots
• 1.3. Major Factors Driving the Market
• 1.4. Top Three Trends Shaping the Market

2. Quit Smoking Drugs Market Characteristics

• 2.1. Market Definition & Scope
• 2.2. Market Segmentations
• 2.3. Overview of Key Products and Services
• 2.4. Global Quit Smoking Drugs Market Attractiveness Scoring And Analysis
  • 2.4.1. Overview of Market Attractiveness Framework
  • 2.4.2. Quantitative Scoring Methodology
  • 2.4.3. Factor-Wise Evaluation
• Growth Potential Analysis, Competitive Dynamics Assessment, Strategic Fit Assessment And Risk Profile Evaluation
• 2.4.4. Market Attractiveness Scoring and Interpretation
• 2.4.5. Strategic Implications and Recommendations

3. Quit Smoking Drugs Market Supply Chain Analysis

• 3.1. Overview of the Supply Chain and Ecosystem
• 3.2. List Of Key Raw Materials, Resources & Suppliers
• 3.3. List Of Major Distributors and Channel Partners
• 3.4. List Of Major End Users

4. Global Quit Smoking Drugs Market Trends And Strategies

• 4.1. Key Technologies & Future Trends
  • 4.1.1 Biotechnology, Genomics & Precision Medicine
  • 4.1.2 Digitalization, Cloud, Big Data & Cybersecurity
  • 4.1.3 Industry 4.0 & Intelligent Manufacturing
  • 4.1.4 Artificial Intelligence & Autonomous Intelligence
  • 4.1.5 Internet of Things (IoT), Smart Infrastructure & Connected Ecosystems
• 4.2. Major Trends
  • 4.2.1 Personalized Nicotine Replacement Therapies
  • 4.2.2 Mobile Health (mHealth) & Smoking Cessation Apps
  • 4.2.3 Telemedicine-Driven Prescription Support
  • 4.2.4 Behavioral Therapy Integration with Drug Therapy
  • 4.2.5 Wearable Devices for Monitoring Cravings

5. Quit Smoking Drugs Market Analysis Of End Use Industries

• 5.1 Adult Smokers
• 5.2 Healthcare Providers
• 5.3 Hospitals & Clinics
• 5.4 Online Health Platforms
• 5.5 Pharmacies & Drug Stores

6. Quit Smoking Drugs Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, Supply Chain Impact from Tariff War & Trade Protectionism, And Covid And Recovery On The Market

7. Global Quit Smoking Drugs Strategic Analysis Framework, Current Market Size, Market Comparisons And Growth Rate Analysis

• 7.1. Global Quit Smoking Drugs PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
• 7.2. Global Quit Smoking Drugs Market Size, Comparisons And Growth Rate Analysis
• 7.3. Global Quit Smoking Drugs Historic Market Size and Growth, 2020 - 2025, Value ($ Billion)
• 7.4. Global Quit Smoking Drugs Forecast Market Size and Growth, 2025 - 2030, 2035F, Value ($ Billion)

8. Global Quit Smoking Drugs Total Addressable Market (TAM) Analysis for the Market

• 8.1. Definition and Scope of Total Addressable Market (TAM)
• 8.2. Methodology and Assumptions
• 8.3. Global Total Addressable Market (TAM) Estimation
• 8.4. TAM vs. Current Market Size Analysis
• 8.5. Strategic Insights and Growth Opportunities from TAM Analysis

9. Quit Smoking Drugs Market Segmentation

• 9.1. Global Quit Smoking Drugs Market, Segmentation By Product, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drug Therapy, E-Cigarettes, Nicotine Inhalers, Nicotine Replacement Therapies, Nicotine Sublingual Tablets
• 9.2. Global Quit Smoking Drugs Market, Segmentation By Drug, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Varenicline (Chantix), Bupropion (Zyban), Other Drugs
• 9.3. Global Quit Smoking Drugs Market, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Drug Store, Online Pharmacies, Retail Pharmacies
• 9.4. Global Quit Smoking Drugs Market, Sub-Segmentation Of Drug Therapy, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Bupropion (Zyban), Varenicline (Chantix)
• 9.5. Global Quit Smoking Drugs Market, Sub-Segmentation Of E-Cigarettes, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Disposable E-Cigarettes, Rechargeable E-Cigarettes, Pod Systems
• 9.6. Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Inhalers, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Prescription Inhalers, Over-The-Counter Inhalers
• 9.7. Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Replacement Therapies, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Nicotine Patches, Nicotine Gum, Nicotine Lozenges
• 9.8. Global Quit Smoking Drugs Market, Sub-Segmentation Of Nicotine Sublingual Tablets, By Type, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• Fast-Acting Sublingual Tablets, Extended-Release Sublingual Tablets

10. Quit Smoking Drugs Market Regional And Country Analysis

• 10.1. Global Quit Smoking Drugs Market, Split By Region, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion
• 10.2. Global Quit Smoking Drugs Market, Split By Country, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

11. Asia-Pacific Quit Smoking Drugs Market

• 11.1. Asia-Pacific Quit Smoking Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 11.2. Asia-Pacific Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

12. China Quit Smoking Drugs Market

• 12.1. China Quit Smoking Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 12.2. China Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

13. India Quit Smoking Drugs Market

• 13.1. India Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

14. Japan Quit Smoking Drugs Market

• 14.1. Japan Quit Smoking Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 14.2. Japan Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

15. Australia Quit Smoking Drugs Market

• 15.1. Australia Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

16. Indonesia Quit Smoking Drugs Market

• 16.1. Indonesia Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

17. South Korea Quit Smoking Drugs Market

• 17.1. South Korea Quit Smoking Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 17.2. South Korea Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

18. Taiwan Quit Smoking Drugs Market

• 18.1. Taiwan Quit Smoking Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 18.2. Taiwan Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

19. South East Asia Quit Smoking Drugs Market

• 19.1. South East Asia Quit Smoking Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 19.2. South East Asia Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

20. Western Europe Quit Smoking Drugs Market

• 20.1. Western Europe Quit Smoking Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 20.2. Western Europe Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

21. UK Quit Smoking Drugs Market

• 21.1. UK Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

22. Germany Quit Smoking Drugs Market

• 22.1. Germany Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

23. France Quit Smoking Drugs Market

• 23.1. France Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

24. Italy Quit Smoking Drugs Market

• 24.1. Italy Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

25. Spain Quit Smoking Drugs Market

• 25.1. Spain Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

26. Eastern Europe Quit Smoking Drugs Market

• 26.1. Eastern Europe Quit Smoking Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 26.2. Eastern Europe Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

27. Russia Quit Smoking Drugs Market

• 27.1. Russia Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

28. North America Quit Smoking Drugs Market

• 28.1. North America Quit Smoking Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 28.2. North America Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

29. USA Quit Smoking Drugs Market

• 29.1. USA Quit Smoking Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 29.2. USA Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

30. Canada Quit Smoking Drugs Market

• 30.1. Canada Quit Smoking Drugs Market Overview
• Country Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 30.2. Canada Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

31. South America Quit Smoking Drugs Market

• 31.1. South America Quit Smoking Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 31.2. South America Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

32. Brazil Quit Smoking Drugs Market

• 32.1. Brazil Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

33. Middle East Quit Smoking Drugs Market

• 33.1. Middle East Quit Smoking Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 33.2. Middle East Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

34. Africa Quit Smoking Drugs Market

• 34.1. Africa Quit Smoking Drugs Market Overview
• Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
• 34.2. Africa Quit Smoking Drugs Market, Segmentation By Product, Segmentation By Drug, Segmentation By Distribution, Historic and Forecast, 2020-2025, 2025-2030F, 2035F, $ Billion

35. Quit Smoking Drugs Market Regulatory and Investment Landscape

36. Quit Smoking Drugs Market Competitive Landscape And Company Profiles

• 36.1. Quit Smoking Drugs Market Competitive Landscape And Market Share 2024
  • 36.1.1. Top 10 Companies (Ranked by revenue/share)
• 36.2. Quit Smoking Drugs Market - Company Scoring Matrix
  • 36.2.1. Market Revenues
  • 36.2.2. Product Innovation Score
  • 36.2.3. Brand Recognition
• 36.3. Quit Smoking Drugs Market Company Profiles
  • 36.3.1. 22nd Century Group Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.2. Cipla Limited Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.3. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.4. GSK Plc. Overview, Products and Services, Strategy and Financial Analysis
  • 36.3.5. Johnson & Johnson Overview, Products and Services, Strategy and Financial Analysis

37. Quit Smoking Drugs Market Other Major And Innovative Companies

• NJOY LLC, Perrigo Company Plc, Pfizer Inc., Philip Morris International, Glenmark Pharmaceuticals Limited, Zydus Cadila Healthcare Limited, BioCorRx Inc., Ennaid Therapeutics LLC, Fertin Pharma A/S, Hikma Pharmaceuticals PLC, IntelGenx Technologies Corp., Innovus Pharmaceuticals Inc., Gilla Inc., Rusan Pharma Ltd., Novartis AG

38. Global Quit Smoking Drugs Market Competitive Benchmarking And Dashboard

39. Key Mergers And Acquisitions In The Quit Smoking Drugs Market

40. Quit Smoking Drugs Market High Potential Countries, Segments and Strategies

• 40.1 Quit Smoking Drugs Market In 2030 - Countries Offering Most New Opportunities
• 40.2 Quit Smoking Drugs Market In 2030 - Segments Offering Most New Opportunities
• 40.3 Quit Smoking Drugs Market In 2030 - Growth Strategies
  • 40.3.1 Market Trend Based Strategies
  • 40.3.2 Competitor Strategies

41. Appendix

• 41.1. Abbreviations
• 41.2. Currencies
• 41.3. Historic And Forecast Inflation Rates
• 41.4. Research Inquiries
• 41.5. The Business Research Company
• 41.6. Copyright And Disclaimer